experimental explants. To overcome the embryonic lethality of both β-catenin and Eomesodermin mutant embryos, we crossed mice with conditional (floxed) β-catenin stabilized, β-catenin null and Eomesodermin null alleles, with the inducible Cre-driver mouse line, Claudin-6CreERT2 which is specific to the endodermal compartment. Also, by tuning the tamoxifen dosage, mosaic recombination will be enabled by the CreERT2 system, and used for clonal studies. At present, we are conducting an exhaustive phenotypical analysis in conjunction with biochemical studies and the establishment of in vitro organoid cultures from mutant and control mice. Disclosing the transcription factor networks involved in endoderm and intestinal progenitor specification is absolutely critical to a better understanding of the ontogeny of various gut diseases, and will encourage the development of novel therapeutics, considerably improving human health. In type-1 diabetic patients glucose homeostasis is regulated by frequent injections of insulin. Beta cell mass can be restored by islet transplantation, but lack of organ donors and the requirement for immunosuppressants make this approach problematic. Recent developments in protocols to differentiate embryonic stem cells to beta cells provide hope for a renewable source of transplantable beta cells. In vertebrates Pdx1-expressing endoderm cells give rise to endocrine and exocrine cell lineages. In previous work we established that development of all pancreatic lineages requires retinoic acid (RA) signaling upstream of Pdx1. However, the gene regulatory network that leads to endocrine pancreas specification downstream of RA signaling is not well characterized. Using an unbiased microarray approach we identified Mnx1 (Hb9) as a RA regulated endoderm transcription factor. By combining manipulation of gene function with transgenic reporter analysis we establish a critical role for Mnx1 in controlling cell fate decisions within the endocrine pancreas progenitor lineage. Previous studies in both zebrafish and mouse have revealed that Mnx1 plays a role in beta cell development. Here, we show that RA signaling regulates the expression of mnx1 in the endoderm, and that mnx1 functions downstream of RA signaling to establish beta cell fate. Published work has shown that morpholino-mediated knock down of zebrafish mnx1 decreases beta cell number. We now demonstrate that in Mnx1-deficient embryos beta cell precursors fail to express insulin and convert to glucagon expressing alpha cells. In summary, we propose that mnx1 functions downstream of RA signaling in the endocrine progenitors to promote beta cell fate. Maturity onset diabetes of the young 5 (MODY5) is a monogenic form of juvenile diabetes caused by heterozygous mutations in the gene encoding the transcription factor HNF1B (Hepatic Nuclear Factor 1B). While MODY5 patients commonly present with a hypoplastic pancreas, it remains unclear how mutations in HNF1B affect developmental of the pancreas or cause diabetes. Currently, only animals with extreme loss of function Hnf1b alleles have been studied, but these models exhibit severe endoderm regionalization defects that preclude analysis of pancreas development and function.
We have now identified a novel zebrafish mutant with a partial loss of function mutation in hnf1b that phenocopies MODY5 pancreatic defects. Using this novel hnf1b mutant, we have uncovered a synthetic genetic interaction with Wnt/β-Catenin signaling in specifying hepatopancreatic progenitors. We are using gain and loss of function experiments to determine the mechanism of their genetic interaction. Our studies suggest that Hnf1b is necessary for Wnt/β-Catenin activity to induce hepatopancreatic development in the endoderm. This work has profound implications for diabetes etiology and may provide insight into the molecular events necessary for in vitro generation of therapeutic pancreas and liver cells. There have been increasing efforts to generate insulin-producing beta-cells in culture for therapeutic uses, drawing on the biological concepts learned from developmental biology. However, these cultures have yet to reproducibly produce glucose-responsive, mature beta-cells, indicating that a greater understanding of the developmental processes to generate fully functional beta-cells is needed. Grg3 (Groucho Related Gene 3) is a member of the Groucho/TLE family of corepressors which facilitates repression of gene expression, and its function in various cell contexts are mediated by its recruitment to target genes by different transcription factors. Grgs broadly regulate the progression of progenitor cells to differentiated cell types and direct cell fate decisions during development. We have found that Grg3 is expressed in most beta-cells and a subset of other endocrine cell types in the fetal and adult mouse pancreas. We have also determined by Ngn3-Cre driven cell lineage tracing experiments that Grg3 is activated in Ngn3+ endocrine progenitor descendants just after transient Ngn3 expression. Analysis of Grg3 knockout embryos determined that a smaller but morphologically normal pancreas (including primary transition glucagon cells) is formed by E13.5. However, the bulk of endocrine differentiation known as the secondary transition occurs around E14, but the vast majority of Grg3 knockout embryos die before E14.5 because of placental defects. Therefore, we explanted E12.5 pancreata to allow differentiation to occur in culture. While control explants displayed all aspects of pancreatic differentiation including exocrine (amylase), ductal (muc1) and endocrine (insulin, glucagon) differentiation, Grg3 knockout explants displayed a drastic decrease (~85% decrease) in endocrine cell Abstracts
